Your browser doesn't support javascript.
loading
Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity.
Dieu, Xavier; Bouzamondo, Nathalie; Briet, Claire; Illouz, Frédéric; Moal, Valérie; Boux de Casson, Florence; Bouhours-Nouet, Natacha; Reynier, Pascal; Coutant, Régis; Rodien, Patrice; Mirebeau-Prunier, Delphine.
Afiliação
  • Dieu X; Laboratoire de Biochimie et Biologie Moléculaire, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France.
  • Bouzamondo N; UMR CNRS 6015-INSERM U1083, 3 rue Roger Amsler, 49100 Angers, France.
  • Briet C; Laboratoire de Biochimie et Biologie Moléculaire, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France.
  • Illouz F; Centre de référence des maladies rares de la thyroïde et des récepteurs hormonaux, CHU Angers, 4 rue Larrey, CEDEX 9,49933 Angers, France.
  • Moal V; UMR CNRS 6015-INSERM U1083, 3 rue Roger Amsler, 49100 Angers, France.
  • Boux de Casson F; Centre de référence des maladies rares de la thyroïde et des récepteurs hormonaux, CHU Angers, 4 rue Larrey, CEDEX 9,49933 Angers, France.
  • Bouhours-Nouet N; Service d'Endocrinologie-Diabétologie-Nutrition, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France.
  • Reynier P; Centre de référence des maladies rares de la thyroïde et des récepteurs hormonaux, CHU Angers, 4 rue Larrey, CEDEX 9,49933 Angers, France.
  • Coutant R; Service d'Endocrinologie-Diabétologie-Nutrition, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France.
  • Rodien P; Laboratoire de Biochimie et Biologie Moléculaire, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France.
  • Mirebeau-Prunier D; Centre de référence des maladies rares de la thyroïde et des récepteurs hormonaux, CHU Angers, 4 rue Larrey, CEDEX 9,49933 Angers, France.
J Clin Med ; 9(7)2020 Jul 03.
Article em En | MEDLINE | ID: mdl-32635414
ABSTRACT
Resistance to thyroid hormone (RTH) is a syndrome characterized by impaired sensitivity of tissues to thyroid hormone (TH). The alteration of TH-binding proteins, such as in Familial Dysalbuminemic Hyperthyroxinemia (FDH), can mimic the abnormal serum thyroid tests typical of RTH. We aimed to characterize a population referred to our center with suspected RTH and estimate the proportion of patients with FDH. For 303 different families, we collected clinical and hormonal data and sequenced the thyroid hormone receptor ß gene (THRB) and exon 7 of the albumin gene (ALB). We found 56 THRB variants (i.e., 38% of the 303 index cases, called RTHß group). Among the samples screened for FDH variants, 18% had the variant R218H in ALB (FDH group); in addition, 71% of the cases had neither variant (non-FDH/RTHß group). Patients with FDH had significantly lower free T3 (fT3) and free T4 (fT4) levels and more often an isolated elevation of fT4 than RTHß patients. Clinically, patients with FDH had fewer symptoms than patients with RTHß. Our study suggests that FDH should be systematically considered when examining patients suspected of having RTH. In most cases, they present no clinical symptoms, and their biochemical alterations show an elevation of fT4 levels, while fT3 levels are 1.11 times below the upper limit of the assay.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França